Volt PFA Catheter Sensor Enabled
ABBOTT MEDICAL · Decision date Mar 23, 2026
What did the FDA approve?
FDA records P250022/S001 as a supplement to PMA P250022, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Mar 23, 2026.
FDA approval order statement
approval for minor design modifications, addition of Alajuela, Costa Rica as a manufacturing site, addition of Minnetonka, Minnesota as a basket subassembly manufacturing site, and addition of two Ethylene Oxide sterilization sites. Additionally, you requested approval for a Pre-Determined Change Control Plan (PCCP) that establishes updates to component suppliers for second source components for the balloon, splines, and center lumen of the catheter, provided they do not impact the specifications, the established methods for its sourcing, handling, and testing, or the qualification standards for supplier facilities and personnel for the devices under the above PMA.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 23, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P250022/S001
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- QZI
- Decision code
- APPR
- Decision date
- Mar 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation.
- Applicant
- Abbott Medical
- Product code
- QZI
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P250022. Subsequent supplements may change the device or its indications.
FDA decision timeline
P250022 · Original PMA
Volt PFA System
P250022/S001 received
Application receipt date recorded by FDA.
P250022/S001 · FDA decision
Normal 180 Day Track
P250022/S004 · Related supplement
Volt PFA Catheter, Sensor Enabled
P250022/S003 · Related supplement
Volt PFA System
P250022/S007 · Related supplement
VOLT PFA CATHETER, SENSOR ENABLED
P250022/S006 · Related supplement
Volt PFA System
P250022/S005 · Related supplement
Current PFA Generator TactiFlex Duo
P250022/S008 · Related supplement
Volt PFA Catheter, Sensor Enabled
P250022/S009 · Related supplement
Volt PFA Catheter, Sensor Enabled
P250022/S012 · Related supplement
VOLT PFA CATHETER, SENSOR ENABLED
P250022/S002 · Related supplement
Volt PFA System
Timeline entries are records held by MedtechLedger for P250022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Volt PFA SystemP250022 | ABBOTT MEDICAL | PMA approval | Dec 19, 2025 | FDA |
Volt PFA Catheter, Sensor EnabledP250022/S004 | ABBOTT MEDICAL | PMA supplement | Apr 13, 2026 | FDA |
Volt PFA SystemP250022/S003 | ABBOTT MEDICAL | PMA supplement | Apr 16, 2026 | FDA |
VOLT PFA CATHETER, SENSOR ENABLEDP250022/S007 | ABBOTT MEDICAL | PMA supplement | Jun 22, 2026 | FDA |
Volt PFA SystemP250022/S006 | ABBOTT MEDICAL | PMA supplement | Jul 10, 2026 | FDA |
Current PFA Generator TactiFlex DuoP250022/S005 | ABBOTT MEDICAL | PMA supplement | Jul 23, 2026 | FDA |
Volt PFA Catheter, Sensor EnabledP250022/S008 | ABBOTT MEDICAL | PMA supplement | Aug 11, 2026 | FDA |
Volt PFA Catheter, Sensor EnabledP250022/S009 | ABBOTT MEDICAL | PMA supplement | Oct 8, 2026 | FDA |
VOLT PFA CATHETER, SENSOR ENABLEDP250022/S012 | ABBOTT MEDICAL | PMA supplement | Oct 8, 2026 | FDA |
Volt PFA SystemP250022/S002 | ABBOTT MEDICAL | PMA supplement | Oct 15, 2026 | FDA |
Explore the linked device profile
Other records with product code QZI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Varipulse Bi-Directional CatheterP240006/S018 | Biosense Webster, Inc. | PMA supplement | Nov 3, 2026 | FDA |
Globe Catheter and Globe Pulsed Field SystemP240044/S007 | Kardium, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Globe Pulsed Field System; Globe CatheterP240044/S008 | Kardium, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Affera Sphere-9 Mapping and Ablation CatheterP240013/S032 | Medtronic, Inc. | PMA supplement | Oct 9, 2026 | FDA |
Sphere-9 Catheter and Affera Ablation SystemP240013/S028 | Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 5050 Nathan Ln. N., Plymouth, MN, 55442
Sources and methodology
- Original FDA record: P250022/S001
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



